A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

1,353

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

November 14, 2023

Study Completion Date

November 14, 2023

Conditions
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
Interventions
DRUG

Bimekizumab

Subjects will receive bimekizumab at pre-specified time-points.

Trial Locations (189)

11415

Ps0014 965, Kew Gardens

14221

Ps0014 947, Buffalo

14623

Ps0014 963, Rochester

20016

Ps0014 934, Washington D.C.

27804

Ps0014 961, Rocky Mount

29650

Ps0014 945, Greer

30022

Ps0014 941, Alpharetta

32174

Ps0014 921, Ormond Beach

33021

Ps0014 906, Hollywood

33134

Ps0014 912, Coral Gables

33144

Ps0014 907, Miami

33437

Ps0014 909, Boynton Beach

33613

Ps0014 936, Tampa

33912

Ps0014 928, Fort Myers

34470

Ps0014 903, Ocala

42301

Ps0014 962, Owensboro

46168

Ps0014 911, Plainfield

48084

Ps0014 917, Troy

50265

Ps0014 900, West Des Moines

60077

Ps0014 954, Skokie

63105

Ps0014 915, Clayton

66210

Ps0014 905, Overland Park

68144

Ps0014 958, Omaha

70115

Ps0014 944, New Orleans

70809

Ps0014 922, Baton Rouge

73112

Ps0014 932, Oklahoma City

75231

Ps0014 931, Dallas

77004

Ps0014 924, Houston

77598

Ps0014 951, Webster

78213

Ps0014 914, San Antonio

84107

Ps0014 933, Murray

85032

Ps0014 946, Phoenix

85308

Ps0014 957, Glendale

90033

Ps0014 927, Los Angeles

90404

Ps0014 967, Santa Monica

92103

Ps0014 919, San Diego

92123

Ps0014 955, San Diego

93309

Ps0014 910, Bakersfield

93405

Ps0014 943, San Luis Obispo

97210

Ps0014 920, Portland

97223

Ps0014 929, Portland

01915

Ps0014 940, Beverly

02135

Ps0014 925, Brighton

03801

Ps0014 901, Portsmouth

08520

Ps0014 908, East Windsor

07044

Ps0014 956, Verona

10029-6501

Ps0014 913, New York

02919

Ps0014 937, Johnston

Unknown

PS0014 7, Campbelltown

PS0014 3, Carlton

PS0014 8, East Melbourne

PS0014 4, Fremantle

Ps0014 10, Kogarah

PS0014 6, Kogarah

PS0014 5, Phillip

PS0014 2, Westmead

PS0014 9, Woolloongabba

Ps0014 50, Brussels

Ps0014 51, Charleroi

Ps0014 52, Liège

Ps0014 658, Ajax

Ps0014 659, Calgary

Ps0014 672, Edmonton

Ps0014 673, Halifax

Ps0014 671, Hamilton

Ps0014 675, Markham

Ps0014 663, Mississauga

Ps0014 660, Montreal

Ps0014 668, North Bay

Ps0014 652, Oakville

Ps0014 667, Ottawa

Ps0014 661, Peterborough

Ps0014 665, Québec

Ps0014 651, Richmond Hill

Ps0014 650, Surrey

Ps0014 676, Surrey

Ps0014 653, Toronto

Ps0014 662, Toronto

Ps0014 664, Toronto

Ps0014 657, Waterloo

Ps0014 669, Windsor

Ps0014 670, Windsor

Ps0014 674, Winnipeg

Ps0014 207, Berlin

Ps0014 218, Bonn

Ps0014 209, Darmstadt

Ps0014 203, Dresden

Ps0014 214, Erlangen

Ps0014 208, Frankfurt

Ps0014 210, Friedrichshafen

Ps0014 202, Hamburg

Ps0014 211, Hamburg

Ps0014 220, Hamburg

Ps0014 212, Heidelberg

Ps0014 215, Lübeck

Ps0014 213, Mahlow

Ps0014 219, Münster

Ps0014 205, Osnabrück

Ps0014 217, Schweinfurt

Ps0014 200, Schwerin

Ps0014 204, Witten

Ps0014 252, Budapest

Ps0014 254, Budapest

Ps0014 255, Budapest

Ps0014 261, Budapest

Ps0014 256, Debrecen

Ps0014 262, Encs

Ps0014 251, Gyula

Ps0014 253, Orosháza

Ps0014 260, Szeged

Ps0014 259, Szekszárd

Ps0014 250, Szolnok

Ps0014 258, Veszprém

Ps0014 300, Roma

Ps0014 303, Roma

Ps0014 629, Asahikawa

Ps0014 605, Bunkyō City

Ps0014 607, Chiyoda-ku

Ps0014 610, Chūōku

Ps0014 601, Fukuoka

Ps0014 619, Gifu

Ps0014 620, Hamamatsu

Ps0014 608, Itabashi-ku

Ps0014 609, Kobe

Ps0014 600, Kurume

Ps0014 622, Matsumoto

Ps0014 604, Minatoku

Ps0014 623, Morioka

Ps0014 621, Nagoya

Ps0014 625, Nankoku

Ps0014 624, Obihiro

Ps0014 611, Osaka

Ps0014 614, Osaka

Ps0014 603, Sapporo

Ps0014 617, Sendai

Ps0014 613, Shimotsuke

Ps0014 602, Shinagawa-ku

Ps0014 612, Shinjuku-ku

Ps0014 618, Shinjuku-ku

Ps0014 626, Shinjuku-ku

Ps0014 628, Shinjuku-ku

Ps0014 606, Takaoka

Ps0014 615, Tokyo

Ps0014 627, Tokyo

Ps0014 616, Tsu

Ps0014 355, Bialystok

Ps0014 361, Bialystok

Ps0014 362, Bialystok

Ps0014 369, Bialystok

Ps0014 371, Bydgoszcz

Ps0014 352, Gdansk

Ps0014 358, Katowice

Ps0014 359, Katowice

Ps0014 366, Katowice

Ps0014 357, Kielce

Ps0014 363, Krakow

Ps0014 360, Lodz

Ps0014 372, Lodz

Ps0014 356, Lublin

Ps0014 364, Nowa Sól

Ps0014 374, Poznan

Ps0014 353, Szczecin

Ps0014 350, Warsaw

Ps0014 351, Warsaw

Ps0014 354, Warsaw

Ps0014 365, Wroclaw

Ps0014 367, Wroclaw

Ps0014 368, Wroclaw

Ps0014 370, Wroclaw

Ps0014 373, Wroclaw

Ps0014 400, Moscow

Ps0014 402, Moscow

Ps0014 403, Moscow

Ps0014 404, Saint Petersburg

Ps0014 405, Saint Petersburg

Ps0014 401, Saratov

Ps0014 406, Yaroslavl

Ps0014 701, Busan

Ps0014 702, Gwangju

Ps0014 705, Seongnam-si

Ps0014 700, Seoul

Ps0014 703, Seoul

Ps0014 754, Taipei

Ps0014 755, Taipei

Ps0014 551, Dundee

Ps0014 552, Liverpool

Ps0014 550, Manchester

Ps0014 554, Reading

Ps0014 555, Salford

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY

NCT03598790 - A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis | Biotech Hunter | Biotech Hunter